Prebiotic Researchers play a crucial role in uncovering the benefits of dietary fibers and non-digestible food ingredients that support gut health. These scientists explore how prebiotics, such as inulin, fructooligosaccharides (FOS), and galactooligosaccharides (GOS), promote the growth of beneficial gut bacteria like Bifidobacteria and Lactobacillus. By studying the interactions between prebiotics and the microbiome, researchers aim to improve digestion, enhance immune function, and prevent gastrointestinal disorders. Recent advancements in prebiotic research focus on personalized nutrition, identifying specific prebiotics that cater to an individual’s gut microbiota composition. Additionally, researchers are investigating novel prebiotics from plant sources, such as polyphenols and resistant starches, to expand their health benefits beyond gut health, including metabolic and cognitive improvements. Prebiotic researchers conduct clinical trials and laboratory studies to analyze the effects of prebiotics on gut health, metabolism, and disease prevention. They investigate how prebiotics influence conditions like irritable bowel syndrome (IBS), obesity, and even mental health through the gut-brain axis. Their work extends to food science, pharmaceutical developments, and personalized nutrition, helping create functional foods and supplements tailored to individual microbiomes.
Prebiotic researchers contribute to food science, pharmaceuticals, and clinical nutrition by developing functional foods and supplements that enhance microbiome diversity. Their work is essential for creating evidence-based dietary recommendations that support overall well-being. Through rigorous clinical trials and microbiome analysis, these experts continue to shape the future of gut health interventions.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India